Sana Biotechnology
SANA
SANA
88 hedge funds and large institutions have $2.48B invested in Sana Biotechnology in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
28% more capital invested
Capital invested by funds: $1.93B → $2.48B (+$545M)
10% more funds holding
Funds holding: 80 → 88 (+8)
6.15% more ownership
Funds ownership: 52.38% → 58.53% (+6.2%)
Holders
88
Holding in Top 10
6
Calls
$15.5M
Puts
$303K
Top Buyers
1 | +$115M | |
2 | +$74M | |
3 | +$22.3M | |
4 |
HMC
Harvard Management Company
Boston,
Massachusetts
|
+$15.6M |
5 |
State Street
Boston,
Massachusetts
|
+$15.3M |
Top Sellers
1 | -$16.3M | |
2 | -$9.37M | |
3 | -$8.49M | |
4 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
-$2.17M |
5 |
Citigroup
New York
|
-$2.15M |